Delivery Order SPE2DB24D2012-SPE2DB25FBWPH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs with a ceiling value of $3,401.68. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract will be performed in...
- The Defense Logistics Agency awarded a delivery order valued at $3,140.47 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector pens (two-pack units). Issued on July 31, 2025, with an ultimate completion date of August 1, 2025, this is a firm fixed-price delivery order utilizing no set-aside designation, indicating competitive award through open procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $2,273.25 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order valued at $1,590.55 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector pens (2-packs) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price contract, which carries no set-aside designation, was competitively awarded and will be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order represents a small-value transaction under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs with a contract value of $1,025.84. This firm fixed-price delivery order is not set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at approximately $1 billion through December 2026. The performance location is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack) with a ceiling value of $1,373.96. This is a firm fixed price delivery order with no set-aside designation, issued through competitive procurement. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Epinephrine 0.3 MG auto-injector (2-pack), with a ceiling value of $2,065.70 and an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of federal pharmaceutical procurement through AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,029.14 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector pens (2-pack units). This firm fixed price, non-set-aside delivery order was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector two-packs, valued at $2,363.36 under a firm fixed-price contract type. The award was made on August 13, 2025, with an ultimate completion date of August 14, 2025, with no set-aside designation applied. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued against...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,040.97 for epinephrine 0.3 mg auto-injector pens (two-pack) on August 8, 2025, with completion scheduled for August 11, 2025. This competitively awarded, firm fixed-price contract represents a pediatric or emergency medical supply procurement supporting federal healthcare systems. The contract is not set-aside and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- SPE2DB24D2012Indefinite Delivery Contract
- SPE2DB24D2012-SPE2DB25FBWPHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of epinephrine 0.3 mg auto-injector pens (2-pack) on August 1, 2025, with a ceiling value of $1,380.14 and ultimate completion date of August 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The contract represents a continuation of AmerisourceBergen's role as a critical federal medical supplier, drawing from the company's broader $999.999 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valid through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a prime vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The epinephrine auto-injector delivery order fulfills federal medical supply requirements for emergency pharmaceutical commodities essential to military and federal healthcare operations. As the child delivery order under the larger SPE2DX global pharmaceutical support contract, this award reflects DLA's strategic procurement approach to maintain reliable access to critical medical products across multiple therapeutic domains and geographic regions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/1/25 |